MyFinsight
Home
About
Contact
Back
Income Statement
FENNEC PHARMACEUTICALS INC. (FENC)
source: myfinsight.com
Download
Download image
Net (loss)/income
-$3,152K
(43.24%↑ Y/Y)
Pedmark product sales,
net
$9,652K
(32.91%↑ Y/Y)
Total other expense
-$420K
(18.29%↑ Y/Y)
(loss)/income from operations
-$2,732K
(45.78%↑ Y/Y)
Unrealized foreign
exchange (loss)/gain
$17K
(200.00%↑ Y/Y)
Interest income
$171K
Total revenues
$9,652K
(32.91%↑ Y/Y)
Unrealized loss on
securities
$1K
Amortization expense
$13K
(-43.48%↓ Y/Y)
Interest expense
$594K
Total operating
expenses
$12,384K
(0.67%↑ Y/Y)
Cost of product sales
$967K
(59.05%↑ Y/Y)
General and
administrative
$6,956K
(1.34%↑ Y/Y)
Research and development
$107K
(-31.85%↓ Y/Y)
Selling and marketing
$4,354K
(-6.81%↓ Y/Y)
Back